2. Search Result
Search Result
Results for "

MP513

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

1

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-14806
    Teneligliptin
    Maximum Cited Publications
    6 Publications Verification

    MP-513

    		 Dipeptidyl Peptidase Metabolic Disease
    Teneligliptin (MP-513) is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor. Teneligliptin competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM .
    Teneligliptin
  • HY-14806A
    Teneligliptin hydrobromide
    Maximum Cited Publications
    6 Publications Verification

    MP-513 hydrobromide

    		 Dipeptidyl Peptidase Metabolic Disease
    Teneligliptin (MP-513) hydrobromide is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM.
    Teneligliptin hydrobromide
  • HY-14806B
    Teneligliptin hydrobromide hydrate
    Maximum Cited Publications
    6 Publications Verification

    MP-513 hydrobromide hydrate

    		 Dipeptidyl Peptidase Metabolic Disease
    Teneligliptin hydrobromide hydrate is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM .
    Teneligliptin hydrobromide hydrate
  • HY-14806S
    Teneligliptin-d8

    MP-513 D8
    Teneligliptin-d8 is a deuterium labeled Teneligliptin (MP-513). Teneligliptin is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor[1].
    Teneligliptin-d8
  • HY-14806S1
    Teneligliptin-d4

    MP-513-d4

    		 Isotope-Labeled Compounds Dipeptidyl Peptidase Metabolic Disease
    Teneligliptin-d4 is deuterium labeled Teneligliptin. Teneligliptin (MP-513) is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor. Teneligliptin competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC50s of approximately 1 nM[1].
    Teneligliptin-d4

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: